Table 4.
Characteristics associated with first chronic opioid in patients with rheumatoid arthritis (RA).
Characteristic | Hazard Ratio* (95% CI) | P-value |
---|---|---|
| ||
Smoking Status (vs. Never smokers) | 0.19 | |
Former | 1.23 (0.70, 2.15) | |
Current | 1.75 (0.96, 3.22) | |
| ||
Highest Education (vs. High School) | 0.24 | |
Graduate School | 1.77 (0.80, 3.94) | |
Technical School/College | 0.81 (0.47, 1.40) | |
<High School | 1.33 (0.54, 3.27) | |
| ||
Treatment for Depression at Index | 0.78 (0.34, 1.83) | 0.57 |
| ||
Treatment for Fibromyalgia at Index | 1.84 (0.58, 5.88) | 0.30 |
| ||
Biologic Use Prior to or at Index | 1.18 (0.55, 2.50) | 0.67 |
| ||
Glucocorticoid Use at Index | 2.48 (1.51, 4.06) | <0.001 |
| ||
RF/ACPA positivity | 1.27 (0.75, 2.16) | 0.37 |
| ||
Rheumatoid nodules | 0.82 (0.49, 1.38) | 0.46 |
| ||
Erosions/destructive changes at index | 1.50 (0.93, 2.41) | 0.10 |
| ||
≥3 ESR measures of ≥60 mm/1 hour** | 0.72 (0.26, 2.02) | 0.54 |
| ||
Years from first joint swelling to fulfillment of criteria for RA | 1.00 (0.90, 1.11) | 0.98 |
Abbreviations: CI=confidence interval, RF=rheumatoid factor,
ACPA=anti-citrullinated protein antibodies, ESR=erythrocyte sedimentation rate
Adjusted for age, sex and duration of rheumatoid arthritis at index date
Prior to index with a minimum interval of 30 days between 2 measurements